← Back to Search

Cancer Diagnostic Device

Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE (ESOGUARDBE1 Trial)

N/A
Waitlist Available
Research Sponsored by Lucid Diagnostics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up cross-sectional point in time per subject through study completion which is up to approximately 5 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial uses the EsoGuard test and EsoCheck device to screen high-risk individuals for Barrett's Esophagus and esophageal cancer by collecting and testing cells from the esophagus.

Eligible Conditions
  • Barrett's Esophagus
  • Esophageal cancer
  • Esophageal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~cross-sectional point in time per subject through study completion which is up to approximately 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and cross-sectional point in time per subject through study completion which is up to approximately 5 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary Efficacy
Secondary study objectives
Secondary Efficacy
Other study objectives
Safety of EsoCheck device administration

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: EsoCheck vs. EGD with or without biopsiesExperimental Treatment1 Intervention
All subjects will undergo both the EsoCheck (non-invasive esophageal cell sample collection) followed by EGD (with or without biopsies)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EsoGuard
2020
N/A
~150

Find a Location

Who is running the clinical trial?

Lucid Diagnostics, Inc.Lead Sponsor
6 Previous Clinical Trials
1,607 Total Patients Enrolled
Randy Brown, MSStudy DirectorLucid Diagnostics
Michelle McDermottStudy DirectorLucid Diagnostics
1 Previous Clinical Trials
470 Total Patients Enrolled
~25 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top